Brainstorm Cell Therapeutics | BCLI - Current Assets


Brainstorm Cell Therapeutics reported $316K in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Biogen USD 7.31B 1.88B Jun/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 137.28M 10.74M Mar/2026
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 1.21B 369.02M Jun/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 933.02M 70.01M Jun/2026
Mesoblast USD 202.48M 1.87M Dec/2025